The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

New study discovers tiny molecules found in blood called piRNA could predict whether older adults are likely to survive two ...

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.

A blood test is a medical procedure where a sample of a person's blood is taken (called a blood draw) and sent to a lab for analysis. Knowing the results of blood tests helps a physician better ...

Early detection tests are already on the market, but without FDA approval or proof they reduce deaths some doctors urge ...

Researchers have evaluated a simple blood test measuring plasma p-tau217 in nearly 600 Latin Americans across six countries, adding large-scale evidence that a potentially lower-cost screening tool ...

Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...